Seventh Sense Biosystems, Inc.

Seventh Sense Biosystems, Inc.

Seventh Sense Biosystems, Inc.

Date Founded



200 Boston Avenue,Suite 3700,Medford, MA 02155

Type of Company


Employees (Worldwide)

11 - 50


Hospitals & Patient Services
IT Consulting & Services
Holding Companies
Medical Support Services
Industrial Machinery & Manufacturing
Electrical Products

Company Description

Seventh Sense Biosystems, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA.

Contact Data
Trying to get in touch with decision makers at Seventh Sense Biosystems, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Operating Officer

Chief Commercial Officer

Chief Business Officer




Chief Executive Officer

Chief Financial Officer

Senior Director, Scientific & Clinical Affairs

Board of Directors

Founder at Alnylam Pharmaceuticals, Inc.

Co-Founder at Moderna, Inc.

Professor at Harvard University

President & Chief Executive Officer at bioTheranostics, Inc.

Chief Executive Officer at Seventh Sense Biosystems, Inc.

Special Partner at Flagship Pioneering

President, Secretary, Treasurer & Director at Exo Therapeutics, Inc.

Paths to Seventh Sense Biosystems, Inc.
Potential Connections via
Relationship Science
Seventh Sense Biosystems, Inc.
Recent Transactions
Details Hidden

Seventh Sense Biosystems, Inc. raised money in a private placement transaction

Details Hidden

Seventh Sense Biosystems, Inc. raised money in a private placement transaction

Details Hidden

Seventh Sense Biosystems, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onSeventh Sense Biosystems, Inc. raised money in a private placement transaction


H.U. Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: Contracted Clinical Testing, Clinical Laboratory Testing, Sterilization related, New Development Business and Others. The Contracted Clinical Testing segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. The Clinical Laboratory Testing segment develops, manufactures and sales diagnostic products globally that are used at medical field for early detection and diagnosis. The Sterilization related segment provides general solutions to the issues facing operating rooms and central materials rooms. It establishes new out-of-hospital centers and promoting automation of operations. The New Development Business and Others segment pertains to newly established food, environment and cosmetic inspection businesses. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Non-Profit Donations & Grants Received
Details Hidden

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Details Hidden

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

Details Hidden

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Seventh Sense Biosystems, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Seventh Sense Biosystems, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Seventh Sense Biosystems, Inc..